When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ICPT - IPO Update: Genfit Files Proposed Terms For IPO And Private Placement
Intercept Pharmaceuticals Inc.
Quick Take
Genfit S.A. (GNFT) intends to raise $130 million in a global IPO from the sale of ADSs representing underlying ordinary shares, per an amended registration statement.
The company is developing treatments for non-alcoholic steatohepatitis [NASH] conditions.
GNFT expects Phase 3 trial results for its primary candidate by the end of 2019 but is asking IPO investors to pay richly for the IPO.
Company & Technology
Loos, France-based Genfit was founded in 1999 to research treatments for non-alcoholic steatohepatitis, fibrosis, and auto-immune conditions.
Management is headed by Chairman, Co-founder and CEO